Hand clinics | 2022 | MacLean SBM, Hu M, Bain GI
Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.
[Indexed for MEDLINE] Conflict of interest statement: Disclosure The authors have nothing to disclose. 13. South Med J. 2016 Sep;109(9):525-30. doi: 10.14423/SMJ.0000000000000516. Osteonecrosis in Sickle Cell Disease. Naseer ZA(1), Bachabi M(1), Jones LC(1), Sterling RS(1), Khanuja HS(1). Author information: (1)From the Department of Orthopaedic Surgery, Johns Hopkins University, Baltimore, Maryland. Osteonecrosis is one of the most devastating musculoskeletal manifestations of sickle cell disease and most commonly affects the femoral head. Although the exact pathophysiology of this condition in patients with sickle cell disease is unknown, it is suggested that red cell sickling and repetitive vaso-occlusion may be associated with tissue hypoxia, inflammation, and subsequent bone necrosis and collapse. If left untreated, osteonecrosis can be extremely debilitating and may lead to severe pain, loss of function, and degenerative joint changes. Although several conservative management approaches exist, total joint arthroplasty remains the most effective treatment intervention. A multidisciplinary approach among the primary care physician, hematologist, and orthopedic surgeon is essential in optimizing patient management. DOI: 10.14423/SMJ.0000000000000516
This article has not been linked to a wiki topic yet.
This article has not been linked to a case yet.
This article has not been linked to an atlas yet.